-Search query
-Search result
Showing 1 - 50 of 88 items for (author: mccallum & m)
EMDB-41639:
Langya henipavirus fusion protein in postfusion state
Method: single particle / : Wang Z, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-41640:
Langya henipavirus fusion protein in prefusion state
Method: single particle / : Wang Z, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-41641:
Langya henipavirus postfusion F protein in complex with the 4G5 Fab, local refinement of the viral membrane distal region
Method: single particle / : Wang Z, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-41642:
Langya henipavirus postfusion F protein in complex with 4G5 Fab, local refinement of the viral membrane proximal region
Method: single particle / : Wang Z, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-41644:
Langya henipavirus postfusion fusion protein in complex with 4G5 Fab (global refinement)
Method: single particle / : Wang Z, Veesler D
PDB-8tve:
Langya henipavirus fusion protein in postfusion state
Method: single particle / : Wang Z, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
PDB-8tvf:
Langya henipavirus fusion protein in prefusion state
Method: single particle / : Wang Z, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-8tvg:
Langya henipavirus postfusion F protein in complex with the 4G5 Fab, local refinement of the viral membrane distal region
Method: single particle / : Wang Z, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
PDB-8tvh:
Langya henipavirus postfusion F protein in complex with 4G5 Fab, local refinement of the viral membrane proximal region
Method: single particle / : Wang Z, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-41636:
Ghanaian virus fusion glycoprotein (GhV F)
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-41643:
Langya Virus G glycoprotein (LayV G) with stabilizing mutations
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-43593:
Langya Virus attachment (G) glycoprotein with K85L/L86K mutation
Method: single particle / : Gibson CG, McCallum MM, Veesler DV
PDB-8tvb:
Ghanaian virus fusion glycoprotein (GhV F)
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
PDB-8tvi:
Langya Virus G glycoprotein (LayV G) with stabilizing mutations
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-8vwp:
Langya Virus attachment (G) glycoprotein with K85L/L86K mutation
Method: single particle / : Gibson CG, McCallum MM, Veesler DV, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-43658:
SARS-CoV-2 S (C.37 Lambda variant) plus S309, S2L20, and S2X303 Fabs
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-43659:
SARS-CoV-2 S NTD (C.37 Lambda variant) plus S2L20 and S2X303 Fabs, local refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-43660:
SARS-CoV-2 S RBD (C.37 Lambda variant) plus S309 Fab, local refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-8vye:
SARS-CoV-2 S (C.37 Lambda variant) plus S309, S2L20, and S2X303 Fabs
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-8vyf:
SARS-CoV-2 S NTD (C.37 Lambda variant) plus S2L20 and S2X303 Fabs, local refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-8vyg:
SARS-CoV-2 S RBD (C.37 Lambda variant) plus S309 Fab, local refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-27779:
Structure of the SARS-CoV-2 spike glycoprotein S2 subunit
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
PDB-8dya:
Structure of the SARS-CoV-2 spike glycoprotein S2 subunit
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-24678:
SARS-CoV-2 S/S2M11/SNAP1 Global Refinement
Method: single particle / : Dang HV, Veesler D
EMDB-24679:
SARS-CoV-2 S/S2M11/SNAP1 Local Refinement
Method: single particle / : Dang HV, Veesler D
EMDB-25990:
SARS-CoV-2 S B.1.1.529 Omicron variant (RBD + S309 Local Refinement)
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-25991:
SARS-CoV-2 S NTD B.1.1.529 Omicron variant + S309 Local Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-25992:
SARS-CoV-2 S B.1.1.529 Omicron variant + S309 + S2L20 Global Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-25993:
SARS-CoV-2 S B.1.1.529 Omicron variant + S309 + S2L20 Global Refinement (Two-open RBDs and one-closed RBD)
Method: single particle / : McCallum M, Veesler D
PDB-7tly:
SARS-CoV-2 S B.1.1.529 Omicron variant (RBD + S309 Local Refinement)
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7tlz:
SARS-CoV-2 S NTD B.1.1.529 Omicron variant + S309 Local Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7tm0:
SARS-CoV-2 S B.1.1.529 Omicron variant + S309 + S2L20 Global Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-25263:
SARS-CoV-2 S B.1.617.2 delta variant + S2M11 + S2L20 Global Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-25264:
SARS-CoV-2 S NTD B.1.617.2 delta variant + S2L20 Local Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-25265:
SARS-CoV-2 S B.1.617.1 kappa variant + S309 + S2L20 Global Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-25266:
SARS-CoV-2 S RBD B.1.617.1 kappa variant S309 Local Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-25267:
SARS-CoV-2 S NTD B.1.617.1 kappa variant S2L20 Local Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-25268:
SARS-CoV-2 S B.1.617.1 kappa variant + S2X303 Global Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-25269:
SARS-CoV-2 S NTD B.1.617.1 kappa variant S2X303 Local Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7so9:
SARS-CoV-2 S B.1.617.2 delta variant + S2M11 + S2L20 Global Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7soa:
SARS-CoV-2 S NTD B.1.617.2 delta variant + S2L20 Local Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7sob:
SARS-CoV-2 S B.1.617.1 kappa variant + S309 + S2L20 Global Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7soc:
SARS-CoV-2 S RBD B.1.617.1 kappa variant S309 Local Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7sod:
SARS-CoV-2 S NTD B.1.617.1 kappa variant S2L20 Local Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7soe:
SARS-CoV-2 S B.1.617.1 kappa variant + S2X303 Global Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7sof:
SARS-CoV-2 S NTD B.1.617.1 kappa variant S2X303 Local Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-24236:
SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-24237:
SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 (Local Refinement of the NTD/S2L20)
Method: single particle / : McCallum M, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
PDB-7n8h:
SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7n8i:
SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 (Local Refinement of the NTD/S2L20)
Method: single particle / : McCallum M, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
Pages: